Nanotechnology Now - News Story: "Asklepios Bio and Bayer Healthcare Sign Research Deal"

Home > News > Asklepios Bio and Bayer Healthcare Sign Research Deal

June 3rd, 2005

Asklepios Bio and Bayer Healthcare Sign Research Deal

Abstract:
Asklepios is currently conducting preclinical testing of a synthetically designed biological nano particle (BNP) gene therapy, containing the factor IX gene for the treatment of hemophilia B.

Source:
triangletechjournal.com

Bookmark:

Related Links

Asklepios Biopharmaceutical Inc.

Bayer HealthCare

Related News Press

Investments/IPO's/Splits

Arrowhead to Present at 2015 Barclays Global Healthcare Conference March 4th, 2015

Arrowhead to Present at 2015 RBC Capital Markets' Global Healthcare Conference February 17th, 2015

Iran 1st among Islamic Nations in Scientific Production, Nanotechnology February 16th, 2015

Harris & Harris Group Portfolio Company D-Wave Systems Raises an Additional $29 Million (CAD), Closing 2014 Financing at $62 Million (CAD) February 2nd, 2015

Nanomedicine

Arrowhead to Present at 2015 Barclays Global Healthcare Conference March 4th, 2015

Democratizing synthetic biology: New method makes research cheaper, faster, and more accessible March 3rd, 2015

Pens filled with high-tech inks for do-it-yourself sensors March 3rd, 2015

New nanodevice defeats drug resistance: Tiny particles embedded in gel can turn off drug-resistance genes, then release cancer drugs March 2nd, 2015

Announcements

CiQUS researchers obtain high-quality perovskites over large areas by a chemical method March 4th, 2015

Arrowhead to Present at 2015 Barclays Global Healthcare Conference March 4th, 2015

Nanosorbents Increase Extraction, Recycling of Silver from Aqueous Solutions March 4th, 2015

Black phosphorus is new 'wonder material' for improving optical communication March 3rd, 2015